Research Analyst Mike Kuchenreuther, Ph.D., provides an in-depth look at recent developments in the French pharmaceutical market in Market Access Outlook in France, published by Pharmaceutical Technology Europe.

Mike identifies pricing and reimbursement challenges, and the implications for manufacturers and their market strategy.  Innovative pricing mechanisms, such as risk sharing, outcomes-based contracting and agreements are becoming more important for optimal pricing.

To read more, click here.